Upcoming Earnings: Q2 '26
Estimated EPS
-$0.01
Estimated Rev
$39.8M
$MRMD Q1 '26 Earnings Results & Recap MariMed reported Q1 2026 revenue of $39.5M, an increase from $37.9M in Q1 2025, and Non-GAAP Adjusted EBITDA grew to $3.6M from $2.5M, expanding its margin to 9%.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | -$0.01 | -- | -- | N/A |
Q1 '26 | -$0.01 | -$0.01 | 20.44% | BEAT |
Q4 '25 | -$0.01 | $0.01 | 155.65% | BEAT |
Q3 '25 | -$0.01 | -$0.01 | -- | EXPECTED |
Q2 '25 | -$0.01 | $0.00 | 100.00% | BEAT |